Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Recombinant Vaccines market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Report Description
Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease. These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue. Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms. There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population. According to Global Agriculture report, there were around 315 million tons of meat produced worldwide in 2014 and expected to increase to 318.8 million tons in 2015.
Market Dynamics
The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future.
National Immunization Program by Queensland Government in Australia and Indradhanush vaccination program in India works to provide vaccination among children throughout the nation. Various organizations such as World Health Organization, World Bank, and United Nations Children's Funds has also taken and initiative to increase vaccination.
Market Taxonomy
The report segments the global recombinant vaccines market on basis of product type, end user, disease type and geography. On the basis of product type, the market is categorized into subunit recombinant vaccines, attenuated vaccines, and vector recombinant vaccines. Among these, the vector recombinant vaccines segment dominates the recombinant vaccines market throughout the forecast period. On the basis of disease type, the market is categorized into infectious disease, cancer, allergy, and others. On the basis of end user, the market is categorized into recombinant human vaccines and animal recombinant vaccines. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased awareness among people and increase in infectious and viral diseases.
Key features of the study:
• This report provides in-depth analysis of the recombinant vaccines market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017-2025)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global Recombinant Vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
• The global recombinant vaccines market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical devices companies, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the recombinant vaccines market
Detailed Segmentation
• Global Recombinant Vaccines Market, By Product Type
o Subunit Recombinant Vaccines
o Attenuated Recombinant Vaccines
o Vector Recombinant Vaccines
• Global Recombinant Vaccines Market, By Disease Type
o Infectious Disease
o Cancer
o Allergy
o Others
• Global Recombinant Vaccines Market, End User
o Recombinant Human Vaccines
o Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Global Recombinant Vaccines Market, By Geography:
 North America
 North America Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 North America Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 North America Recombinant Vaccines Market, End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 North America Recombinant Vaccines Market, By Country:
 U.S.
 U.S. Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 U.S. Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 U.S. Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Canada
 Canada Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Canada Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Canada Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Europe
 Europe Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Europe Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Europe Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Europe Recombinant Vaccines Market, By Country:
 Germany
 Germany Recombinant Vaccines Market, Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Germany Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Germany Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 U.K.
 U.K. Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 U.K. Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 U.K. Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 France
 France Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 France Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 France Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Italy
 Italy Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Italy Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Italy Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Spain
 Spain Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Spain Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Spain Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Russia
 Russia Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Russia Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Russia Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Rest of Europe
 Rest of Europe Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Rest Of Europe Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Rest Of Europe Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Asia Pacific
 Asia Pacific Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Asia Pacific Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Asia Pacific Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Asia Pacific Recombinant Vaccines Market, By Country:
 China
 China Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 China Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 China Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 India
 India Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 India Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 India Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Japan
 Japan Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Japan Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Japan Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Australia
 Australia Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Australia Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Australia Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture vaccines
 South Korea
 South Korea Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 South Korea Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 South Korea Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 ASEAN
 ASEAN Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 ASEAN Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 ASEAN Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Rest of Asia Pacific
 Rest of Asia Pacific Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Rest of Asia Pacific Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Rest of Asia Pacific Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Latin America
 Latin America Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Latin America Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Latin America Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Latin America Recombinant Vaccines Market, By Country:
 Brazil
 Brazil Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Brazil Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Brazil Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Mexico
 Mexico Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Mexico Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Mexico Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Argentina
 Argentina Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Argentina Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Argentina Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Rest of Latin America
 Rest of Latin America Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Rest of Latin America Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Rest of Latin America Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Middle East
 Middle East Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Middle East Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Middle East Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Middle East Recombinant Vaccines Market, By Country:
 GCC
 GCC Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 GCC Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 GCC Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Israel
 Israel Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Israel Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Israel Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Rest of Middle-East
 Rest of Middle-East Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Rest of Middle-East Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Rest of Middle-East Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
o Africa
 Africa Recombinant Vaccines Market, By Product Type:
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Africa Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Africa Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Aquaculture Vaccines
 Africa Recombinant Vaccines Market, By Country:
 North Africa
 North Africa Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 North Africa Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 North Africa Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 Central Africa
 Central Africa Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 Central Africa Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 Central Africa Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
 South Africa
 South Africa Recombinant Vaccines Market, By Product Type
 Subunit Recombinant Vaccines
 Attenuated Recombinant Vaccines
 Vector Recombinant Vaccines
 South Africa Recombinant Vaccines Market, By Disease Type
 Infectious Disease
 Cancer
 Allergy
 Others
 South Africa Recombinant Vaccines Market, By End User
 Recombinant Human Vaccines
 Animal Recombinant Vaccines
 Poultry
 Companion Animal Vaccines
 Livestock
 Porcine
• Company Profiles
o Merck & Co., Inc.,*
 Company Overview
 Product Portfolio
 Market Presence
 Financial Overview
 Key Developments
 Strategies
o Green Cross Corporation
o Pfizer Inc.
o Bayer AG
o Sanofi S A.
o Protein Science Corporation
o GlaxoSmithKline Plc.
o Novartis AG
o Bharat Biotech

"*" marked represents similar segmentation in other categories in the respective section.


Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Product Type
? Market Snippet By Disease Type
? Market Snippet By End User
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Regulatory Scenario
o Industry Trend
o Epidemiology/Prevalence/Incidence
o Merger and Acquisitions
o New Product Type Approvals/Launch
o Promotion and Marketing Initiatives
4. Global Recombinant Vaccines Market, By Product Type, 2015 - 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Subunit Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
o Attenuated Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
o Vector Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
5. Global Recombinant Vaccines Market, By Disease Type, 2015 - 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Infectious Disease
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
o Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
o Allergy
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
6. Global Recombinant Vaccines Market, By End User, 2015 - 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2015 - 2025
? Segment Trends
o Recombinant Human Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
o Animal Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
? Poultry
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
? Companion Animal Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
? Livestock
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
? Porcine
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
? Aquaculture Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)
7. Global Recombinant Vaccines Market, By Regions, 2015 - 2025 (USD Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, For Regions, 2015 - 2025
o North America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? U.S.
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Canada
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
o Europe
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? U.K.
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Germany
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Italy
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? France
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Russia
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
o Asia Pacific
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? China
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? India
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Japan
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Australia
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
o Latin America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? Brazil
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
o Africa
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? Northern Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
o Middle East
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2015 - 2025
? GCC Countries
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
? Israel
? Country Trends
? Market Size and Forecast, By Product Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By Disease Type, 2015 - 2025 (USD Million)
? Market Size and Forecast, By End User, 2015 - 2025 (USD Million)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Merck & Co., Inc.
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Green Cross Corporation
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Pfizer, Inc.
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Sanofi S A.
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Protein Science Corporation
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? GlaxoSmithKline Plc
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Bharat Biotech
? Company Overview
? Product Type Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 36 market data tables and 107 figures on "Recombinant Vaccines(CGM) Market - Global forecast to 2025".

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us